Chemotherapy-Free Management of Follicular and Marginal Zone Lymphoma

Many patients with follicular (FL) or marginal zone lymphoma (MZL) are not eligible to receive immunochemotherapy due to advanced age or comorbidities. Recent innovations in the treatment of these indolent lymphomas provide options for multiple lines of chemotherapy-free management. More research is...

Descripción completa

Detalles Bibliográficos
Autores principales: Ollila, Thomas A, Olszewski, Adam J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131013/
https://www.ncbi.nlm.nih.gov/pubmed/34017197
http://dx.doi.org/10.2147/CMAR.S267258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131013/
https://www.ncbi.nlm.nih.gov/pubmed/34017197
http://dx.doi.org/10.2147/CMAR.S267258

Ejemplares similares